DCT

1:24-cv-00039

Regeneron Pharma Inc v. Amgen Inc

General
Filed
04/16/24
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company
Nature of Suit830 Patent
Judge
Period
PO Win Rate
--
91%